Recherche
-
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
(Diabetes. vol. 70, n° 2, pp. 415-422, 2021-02)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
(Revue Neurologique. vol. 177, n° 1-2, pp. 73-79, 2021-01)Article de revue